Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
Authors
Keywords
-
Journal
mAbs
Volume 10, Issue 6, Pages 864-875
Publisher
Informa UK Limited
Online
2018-08-07
DOI
10.1080/19420862.2018.1486946
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
- (2016) Eva Billerbeck et al. JOURNAL OF HEPATOLOGY
- Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells
- (2016) Michael Dillon et al. mAbs
- Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab
- (2015) Fan Zhang et al. OncoImmunology
- Herceptin Resistance Database for Understanding Mechanism of Resistance in Breast Cancer Patients
- (2014) Sahil Ahmad et al. Scientific Reports
- Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization
- (2013) B. Li et al. CANCER RESEARCH
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant
- (2012) Peiqing Zhang et al. GLYCOBIOLOGY
- Dual targeting strategies with bispecific antibodies
- (2012) Roland Kontermann mAbs
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
- (2012) Thuy Vu et al. Frontiers in Oncology
- Activity and resistance of trastuzumab according to different clinical settings
- (2011) Elda Tagliabue et al. CANCER TREATMENT REVIEWS
- The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
- (2011) Suzanne A. Eccles INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Structural Insights into the Down-regulation of Overexpressed p185her2/neuProtein of Transformed Cells by the Antibody chA21
- (2011) Huihao Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer
- (2010) Teemu T. Junttila et al. CANCER RESEARCH
- CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer
- (2010) José Baselga et al. Clinical Breast Cancer
- Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy
- (2010) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
- (2009) W. Scheuer et al. CANCER RESEARCH
- Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions
- (2008) John Valliere-Douglass et al. JOURNAL OF CHROMATOGRAPHY A
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now